These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 19943877

  • 1. Direct fibrinolytic agents: biochemical attributes, preclinical foundation and clinical potential.
    Marder VJ, Novokhatny V.
    J Thromb Haemost; 2010 Mar; 8(3):433-44. PubMed ID: 19943877
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Alfimeprase.
    Drugs R D; 2008 Mar; 9(3):185-90. PubMed ID: 18457471
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Fibrolase: trials and tribulations.
    Markland FS, Swenson S.
    Toxins (Basel); 2010 Apr; 2(4):793-808. PubMed ID: 22069611
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Staphylokinase--a specific plasminogen activator].
    Rozpończyk E, Szemraj J, Malinowski M, Rozpończyk J.
    Postepy Biochem; 2006 Apr; 52(1):80-6. PubMed ID: 16869305
    [Abstract] [Full Text] [Related]

  • 9. Biochemical characteristics of fibrolase, a fibrinolytic protease from snake venom.
    Ahmed NK, Tennant KD, Markland FS, Lacz JP.
    Haemostasis; 1990 Apr; 20(3):147-54. PubMed ID: 1696922
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Identification and Characterization of Plasmin-Independent Thrombolytic Enzymes.
    Hassan MM, Sharmin S, Kim HJ, Hong ST.
    Circ Res; 2021 Feb 05; 128(3):386-400. PubMed ID: 33292062
    [Abstract] [Full Text] [Related]

  • 12. Drug evaluation: alfimeprase, a plasminogen-independent thrombolytic.
    Shah AR, Scher L.
    IDrugs; 2007 May 05; 10(5):329-35. PubMed ID: 17487785
    [Abstract] [Full Text] [Related]

  • 13. The fibrinolytic system in man.
    Collen D, Lijnen HR.
    Crit Rev Oncol Hematol; 1986 May 05; 4(3):249-301. PubMed ID: 2420482
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thrombolysis with plasmin: implications for stroke treatment.
    Marder VJ, Jahan R, Gruber T, Goyal A, Arora V.
    Stroke; 2010 Oct 05; 41(10 Suppl):S45-9. PubMed ID: 20876504
    [Abstract] [Full Text] [Related]

  • 17. New developments in thrombolytic therapy.
    Collen D, Gold HK.
    Adv Exp Med Biol; 1990 Oct 05; 281():333-54. PubMed ID: 2129372
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Non-clinical and clinical characterization of a novel acting thrombolytic: alfimeprase.
    Deitcher SR, Toombs CF.
    Pathophysiol Haemost Thromb; 2005 Oct 05; 34(4-5):215-20. PubMed ID: 16707931
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of action and thrombolytic potential of staphylokinase.
    Lijnen HR.
    Verh K Acad Geneeskd Belg; 1995 Oct 05; 57(4):303-14. PubMed ID: 8571666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.